Lv32
300 积分 2024-05-21 加入
177Lu-FAPI-2286 Therapy in a Patient With Radio-iodine Refractory Papillary Thyroid Carcinoma: A Favorable Clinical and Biochemical Response
7小时前
已完结
177Lu-FAP-2286 Therapy in a Case of Squamous Lung Cancer
7小时前
已完结
Exploring the FAP-Targeted Therapeutics for Adrenocortical Carcinoma Choosing the Right Track
7小时前
已完结
Efficacy and Safety of [177Lu]Lu-DOTAGA.Glu.(FAPi)2 Therapy in Patients with Sarcoma
1天前
已完结
Covalent targeted radioligands potentiate radionuclide therapy
2个月前
已完结
Single vial kit formulation of DOTATATE for preparation of 177Lu-labeled therapeutic radiopharmaceutical at hospital radiopharmacy
4个月前
已完结
18F-Labeling Chemistry in Aqueous Media
5个月前
已完结
Peptide Targeted Radiotherapy using cancer-associated fibroblasts as target in solid tumors: first clinical experience with the 177Lu-, 225Ac- and 90Y-labeled peptide 3BP-3940 (single isotope and TANDEM) targeting the Fibroblast Activating Protein
6个月前
已关闭
90Y SIR-Spheres Activity Measurement with New SIROS D-Vial Delivery Kit
6个月前
已关闭
Chelators and metal complex stability for radiopharmaceutical applications
7个月前
已完结
皖公网安备34019202002308
